Lagevrio
Generic name: molnupiravir
Drug class: Miscellaneous antivirals
What is Lagevrio?
Lagevrio is an experimental medicine being studied for the treatment of mild-to-moderate COVID-19. This drug is still being studied and all of its risks are not yet known.
The US Food and Drug Administration (FDA) has authorized emergency use of molnupiravir for the treatment of mild-to-moderate COVID-19 in people 18 years of age and older:
-
who are at high risk for progression to severe COVID-19, including hospitalization or death; and
-
for whom other COVID-19 treatment options are not available or applicable.
Lagevrio is not authorized for use:
-
in anyone younger than 18 years old;
-
for initiation of treatment in people needing hospitalization due to COVID-19;
-
for prevention before or after exposure of COVID-19; or
-
longer than 5 consecutive days.
Lagevrio may also be used for purposes not listed in this medication guide.
Lagevrio side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, trouble swallowing, rapid heartbeat, swelling of your face, lips, tongue, or throat.
Call your doctor if you have any new or worsening symptoms.
Common side effects of Lagevrio may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Warnings
The US Food and Drug Administration (FDA) has authorized emergency use of molnupiravir for the treatment of mild-to-moderate COVID-19 in people 18 years of age and older.
Before taking this medicine
Tell your doctor if you have any allergies or other medical conditions.
Lagevrio may harm an unborn baby if the mother or father is using Lagevrio:
-
If you are a woman, do not use Lagevrio if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 4 days after your last dose.
-
If you are a man, use an effective birth control if your sex partner is pregnant or is able to get pregnant. Keep using birth control for at least 3 months after your last dose.
-
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Lagevrio.
You may need to have a negative pregnancy test before starting this treatment.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of molnupiravir on the baby.
Do not breastfeed while using this medicine, and for at least 4 days after your last dose. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.
How should I take Lagevrio?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Take Lagevrio (four capsules) every 12 hours for 5 consecutive days.
The content of the open capsules may also be given through a feeding tube. Read and carefully follow the instructions provided on how to prepare a mixture of the open capsules. Ask your doctor or pharmacist if you do not understand these instructions.
Take this medicine as soon as possible after diagnosis of COVID-19 and within 5 days of when symptoms first appear. Do not stop the medicine without your doctor's advice.
You may take Lagevrio with or without food.
Swallow the capsule whole and do not crush, chew, break, or open it.
Being treated with Lagevrio will not make you less contagious to other people. Keep using infection control methods such as self-isolation, social distancing, hand-washing, using protective face covering, disinfecting surfaces you touch a lot, and not sharing personal items with others.
What happens if I miss a dose?
Use the medicine as soon as you can, but skip the missed dose if you are more than 10 hours late for the dose. Do not use two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking Lagevrio?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect Lagevrio?
Other drugs may affect Lagevrio, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Popular FAQ
How do Paxlovid and molnupiravir compare for COVID-19?
Paxlovid (nirmatrelvir and ritonavir) and Lagevrio (molnupiravir) are two oral treatment options for mild-to-moderate coronavirus disease 2019 (COVID-19) in people who are at high risk for severe COVID-19 disease. However, they have some key differences. Continue reading
More about Lagevrio (molnupiravir)
- Compare alternatives
- Pricing & coupons
- Reviews (13)
- Drug images
- Side effects
- Dosage information
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 2.02.